Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/30147
Title: Cryptococcosis in Patients with Hematologic Diseases
Authors: GUARANA, MarianaVIDAL, Jose ErnestoNUCCI, Marcio
Citation: CURRENT FUNGAL INFECTION REPORTS, v.12, n.4, p.187-194, 2018
Abstract: Purpose of Review In this paper, we reviewed the epidemiology, diagnosis, and treatment of cryptococcosis in patients with hematologic malignancies. We reviewed all case series of cryptococcosis in different hematologic conditions, and looked at epidemiologic trends considering the new antineoplastic drugs introduced in the treatment of hematologic malignancies. Recent Findings Case series of cryptococcosis in patients with hematologic malignancies are scarce. We identified an increase in the proportion of cases of cryptococcosis occurring in patients with hematologic malignancies, and many case reports of cryptococcosis in patients receiving ibrutinib, a Bruton kinase inhibitor used in the treatment of chronic lymphoproliferative diseases. Summary Cryptococcosis is uncommon in patients with hematologic malignancies, but its occurrence may be associated with poor outcome. Hematologists should be aware of this complication if patients develop neurologic symptoms or present with pulmonary infiltrates that do not improve with antibiotics.
Appears in Collections:Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - IMT
Artigos e Materiais de Revistas Científicas - LIM/49

Files in This Item:
File Description SizeFormat 
art_GUARANA_Cryptococcosis_in_Patients_with_Hematologic_Diseases_2018.PDF
  Restricted Access
publishedVersion (English)417.89 kBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.